BALAXI - Balaxi Pharmaceuticals

Balaxi Pharmaceuticals

BALAXI · Retail > Trading · MD: Ashish Maheshwari · Listing date: Nov. 30, 2015 · Hyderabad · http://www.balaxiventures.in/

Stock Price vs Company Growth

1.6%

3.0%

6.3%

4.9%

39.0%

17.2%

55.3%

all

55.5%

🤔 How to analyze this graph?

Last Traded Price

₹ 121 1.6%

151

Company Overview

Sales

241 Cr

Growth: -16.0%

Profit after Tax

-10.8 Cr

Growth: -14.0%

Small Cap

669 Cr

P/S: 2.8x

Industry P/S: 1.9x

Fundamentals

Sales (Cr)	₹ 241
Growth	-16.0%
EBITDA	19.4%
P/S	2.8x
Dividend	0.0%
P/E	-266.0x
Book Value	₹ 27
PEG Ratio	16.5x
ROE	-8.1%
P/B	4.4x

Shareholding Pattern

Institutions

Elara India Opportunities Fund Limited

9.5 %

Marshal Global Capital Fund Ltd

9.5 %

Amol Anand Mantri

1.73 %

Iepf

0.75 %

Promoters

Balaxi Overseas Private Limited

70.0 %

Ashish Maheshwari

1.81 %

Minoshi Maheshwari

1.06 %

Others

Increase Decrease No change

Company Profile Detailed

The company is engaged in the business of international wholesale trading of Pharmaceuticals, Builders Hardware and FMCG productsHistory and Milestones2003-07Commenced Pharmaceutcal business by supplying white labeled products to customers in Africa.Sourcing was from WHO GMP certified plants based in India.2008-10Created frontend presence for its Pharmaceutical Business by setting up 1st wholesale depot in Angola in 2008.

Investors (12)

iepf

p.p.zibi

balaxi.o...

Followers (1)

gmuralik